Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer

OBJECTIVES: To examine the cost-effectiveness of primary debulking surgery (PDS) when compared to neoadjuvant chemotherapy (NACT) in the management of epithelial ovarian cancer (EOC) using Surveillance, Epidemiology, and End Results data linked to Medicare claims (SEER-Medicare). METHODS: Using a Ma...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clinicoecon Outcomes Res
Auteurs principaux: Forde, Gareth K, Chang, Jenny, Ziogas, Argyrios
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2016
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4976818/
https://ncbi.nlm.nih.gov/pubmed/27536150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S91844
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires